Study Statistics

StudyRR [95% Conf. Interval]% Weight
Nauck, 20091.1180.3343.7388.04
Russell-Jones1.6431.0782.50565.97
Zinman, 20091.5470.6873.48117.81
Marre, 20093.0850.93210.2128.18
D+L pooled RR1.6601.1782.337100.00

Heterogeneity chi-squared = 1.49 (d.f. = 3) p = 0.685

I-squared (variation in RR attributable to heterogeneity) = 0.0%

Estimate of between-study variance Tau-squared = 0.0000

Test of RR=1 : z= 2.90 p = 0.004

From: Appendix E, Meta-analyses

Cover of Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations
Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report [Internet].
Jonas D, Van Scoyoc E, Gerrald K, et al.
Portland (OR): Oregon Health & Science University; 2011 Feb.
Copyright © 2011, Oregon Health & Science University.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.